← Leaderboards
Paul Matthew Herrinton
Boropharm, Inc.
$1,185,102
Attributed
$1,185,102
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $556.5K · FY2008–11$1M$750K$500K$250K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$1,185,102 · 2
By mechanism
R44$1,031,874 · 1
R43$153,228 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Interest”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- David Heimbrook · Leidos Biomedical Research, Inc.$231,553,599
- Clare E Reimers · Gordon Research Conferences$206,081,841
Research focus
InterestMalariaIndustrial FungicideIn SituIridiumLicensingFood SupplyHydroxypyridinesBoronInsectaFunctional GroupAreaBoronic AcidsLaboratoriesBenignCostBaseHepatoprotective AgentDrug CostsDrug DiscoveryEstersCatalystCharacteristicsMarketing
Grant awards (3)
Phase II Environmentally greener, efficient, and safe synthetic platform for the$475,412
R44 · FY2011 · GM · contact PI
Phase II Environmentally greener, efficient, and safe synthetic platform for the$556,462
R44 · FY2010 · GM · contact PI
Environmentally greener, efficient, and safe synthetic platform for the productio$153,228
R43 · FY2008 · GM · contact PI